Biochips Market Report

Biochips Market Report, By Product Type (DNA Chips, Protein Chips and Lab-On-A-Chip), Technology (Microfluidics and Microarray), Application (Genomics, Proteomics, Drug Discovery & Development and In-Vitro Diagnostics) and Geography - Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : hc1976 | Publish Date : Upcoming | Industry : Healthcare | Geography : Global


Biochip is a set of diminished microarrays which are placed on a strong substrate that allows many experiments to be executed at the same time to obtain a high throughput in less time. This device contains millions of sensor elements or biosensors. Biochip has been extensively studied and developed to enable large-scale genomic, proteomic and functional genomic analyses. Moreover, biochip comprises mainly three types such as DNA microarray, protein microarray, and microfluidic chip. With the integration of microarray and microfluidic systems, a micro total analysis system, which is often called a lab-on-a-chip (LOC) system, is produced. Furthermore, advances of nanotechnology have continuously reduced the size of the biochip which in turn reduced the manufacturing cost and increased the high throughput capability. Owing to all these benefits, this technology has great potential to be a key and powerful tool for clinical research, diagnostics, drug development and toxicology studies. 

Biochips Market Outlook

Some of the key factors driving the biochips market are increasing adoption of targeted & personalized medicine across the globe, rising applications of biochips and advancement in technology. However, the growth of the biochips market is hampered due to the High instrumentation costs and unclear regulatory guidelines. Moreover, the factors such as significant growth prospects in developing countries is the major opportunity in the biochips market. 


Biochips Market Segmental Overview

The biochips market is segmented by product type, technology, application and geography.

Biochips Market by Product Type

Based on product type, the biochips market is segmented into DNA chips, protein chips, lab-on-a-chip and others. Furthermore, others segment is classified into cell arrays and tissue arrays. The DNA chips are widely used around the world owing to its extensive applications in fields such as gene expression, drug discovery, genomic studies, cancer treatment and diagnosis. Furthermore, the high demand for analysis and recognition of genomic disorders are the factors propelling business growth.

Biochips Market by Technology

The technologies discussed in this market are microfluidics and microarray. Owing to the rising demand for POC diagnostic devices such as glucose monitoring and pregnancy test kits, the microfluidics segment is projected to witness the fastest growth in near future.  

Biochips Market by Application

Various application were studied in this report such as genomics, proteomics, drug discovery & development and in-vitro diagnostics. The development of biochips has progressively influenced the growth of the miniaturization of products and the automation of processes. The application of biochips in drug discovery and development is expected to be high. Moreover, expression monitoring is the most biologically informative application of this technology at present. Microarray technology has important applications in pharmacogenomics such as drug discovery & development, drug safety and molecular diagnostics. DNA chips have facilitate the integration of diagnosis and therapeutics, as well as the introduction of personalised medicines.

Biochips Market by Geography

Based on geography, the biochips market is segmented into North America, Europe, Asia Pacific and rest of the world. North America dominated the market in 2018. Growth in this region is majorly driven by the rising prevalence of lifestyle diseases & cardiac disorders and increasing geriatric population in the region. Owing to increasing biotechnology and pharmaceutical companies and low infrastructure costs, the Asia-Pacific is the fastest growing region in the biochips market globally. 

Biochips Market Key Players 

The key market players that are dominating the biochips market include Abbott Laboratories, Agilent Technologies, Inc., Perkinelmer, Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare, Bio-Rad Laboratories Inc., Cepheid Inc., Thermo Fisher Scientific, Inc. and Roche Diagnostics. Leading companies have invested massive capital in research & development and mergers & acquisitions activities to develop innovative products in the market. 

Biochips Market Key Developments

  • March 2016: Thermo Fisher Scientific Inc. and Affymetrix, Inc. announced the acquisition of Affymetrix for USD 14.00 per share in cash, for a total purchase price of approximately USD 1.3 billion. This acquisition helped Thermo Fisher to strengthen its leadership in biosciences, as well as acquire new genetic analysis capabilities to better serve clinical and applied markets.
  • July 2016: Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, has announced the launch of its research use variaTECT genetic biomarker test for assessing Alzheimer’s disease (AD) risk. The variaTECT SNP (single nucleotide polymorphism) array offers a simple blood-based research test providing a comprehensive panel of AD informative SNPs to assist research and novel drug discovery studies
  • July 20, 2015 Cytox Ltd and Affymetrix announced a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI).

The biochips market is segmented by product type, technology, application and geography. Based on product type, these market is segmented into DNA chips, protein chips, lab-on-a-chip and others. Furthermore, others segment is classified into cell arrays and tissue arrays. The DNA chips are widely used around the world owing to its extensive applications in fields such as gene expression, drug discovery, genomic studies, cancer treatment and diagnosis. Furthermore, the high demand for analysis and recognition of genomic disorders are the factors propelling business growth.


The technologies discussed in this market are microfluidics and microarray. Owing to the rising demand for POC diagnostic devices such as glucose monitoring and pregnancy test kits, the microfluidics segment is projected to witness the fastest growth in near future.  


Various application were studied in this report such as genomics, proteomics, drug discovery & development and in-vitro diagnostics. The development of biochips has progressively influenced the growth of the miniaturization of products and the automation of processes. The application of biochips in drug discovery and development is expected to be high. Moreover, expression monitoring is the most biologically informative application of this technology at present. Microarray technology has important applications in pharmacogenomics such as drug discovery & development, drug safety and molecular diagnostics. DNA chips have facilitate the integration of diagnosis and therapeutics, as well as the introduction of personalised medicines.


Based on geography, the market is segmented into North America, Europe, Asia Pacific and rest of the world. North America dominated the market in 2018. Growth in this region is majorly driven by the rising prevalence of lifestyle diseases & cardiac disorders and increasing geriatric population in the region. Owing to increasing biotechnology and pharmaceutical companies and low infrastructure costs, the Asia-Pacific is the fastest growing region in the biochips market globally. 


Why to buy this report:

  • The report offers changing market dynamics in the biochips market, presenting historical, current and projected market size in terms of value (USD million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of biochips, such as cell arrays market, diagnostics market etc.
  • It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the biochips market performance
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of biochips market